HomeBUSINESS
BUSINESS

Aspen Takes Over Arixtra from GSK, Transfer Pact Completed in Japan
(Nov.1.2017)

Aspen Japan said on October 31 that it has taken over the marketing authorization for the synthetic factor Xa inhibitor Arixtra (fondaparinux) from GlaxoSmithKline ...
(LOG IN FOR FULL STORY)

News Calendar